Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026)

Amneal Pharmaceuticals' Receivables - Net history runs 10 years deep, the most recent figure standing at $508000.0 for Q1 2026.

• In Q1 2026, Receivables - Net rose 1932.0% year-over-year to $508000.0; the TTM figure through Mar 2026 stood at $508000.0 (up 1932.0% YoY), while the FY2025 annual figure was $1000.0, down 100.0% from the prior year.
• Receivables - Net was $508000.0 for Q1 2026 at Amneal Pharmaceuticals, up from $1000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.3 billion in Q2 2025 to a low of $1000.0 in Q4 2025.
• Historically, Receivables - Net has averaged $664.8 million across 5 years, with a median of $688.8 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Receivables - Net surged 246809.47% in 2023, then tumbled 100.0% in 2025.
• A 5-year view of Receivables - Net shows it stood at $486000.0 in 2022, then soared by 246809.47% to $1.2 billion in 2023, then tumbled by 35.35% to $775.7 million in 2024, then sank by 100.0% to $1000.0 in 2025, then soared by 50700.0% to $508000.0 in 2026.
• The last three Receivables - Net figures came in at $508000.0 (Q1 2026), $1000.0 (Q4 2025), and $885.2 million (Q3 2025), per Business Quant data.